Lifeboat Foundation

https://youtube.com/watch?v=LTTX2408n3o

Technology is amazing and can be used to help so many. When I position technology; I do so in showing how it helps folks to combat devastating diseases, live life fully even if they became paralyzed at some point in their life and with technology they can walk again, etc. I caution folks to ensure that when we introduce technology that we explain our message well to the broader masses; or risk not be adopted.

We have to do a better job in explaining how AI, BMI, etc. will help the population. When we present things like BMI, Cell Circuitry, etc. we must market how folks used the technology to combat a disease, a disability, or be able to live a more fuller life, etc. I keep seeing either no message or the wrong message being presented to the masses. Instead of waiting for the technology being available; we must take consumers on a journey of possibilities that they can have with tech.

Continue reading “Religion plays a role in attitudes toward human enhancement technologies” »

Southern US is having a bad summer. Zika in FL and Brain eating amoebas in SC.

CHARLESTON COUNTY, S.C. — A patient in South Carolina has tested positive for Naegleria fowleri, the so-called “brain-eating amoeba,” The Centers for Disease Control confirmed in a statement.

Health officials think the patient may have been exposed during a July 24 swim at Martin’s Landing in the Edisto River, which runs through the southeast portion of the state through the Ernest F. Hollings Ace Basin National Wildlife park.

Continue reading “South Carolina patient has rare ‘brain-eating’ amoeba, CDC confirms” »

The findings showed that the shrinking of the hippocampus — brain region associated with learning and memory — actually precedes the onset of a change in behaviour — namely the loss of memory. “Until now, no one knew the evolution of these changes. Does the hippocampus shrink before or after memory loss? Or do the two happen handin- hand,” said Sumantra Chattarji, Professor at National Centre for Biological Sciences in Bengaluru, Karnataka, in a statement.

Using rats as a model system which reacts to stress much as humans do, the team studied how the brain changes in structure during stress. The results showed that when under stress, rats develop anxiety-related behaviours and their ability to form memories are affected. In the study, rats were subjected to stress for two hours every day over 10 days. The brains were examined with MRI scans on several days over the course of the study, and their ability to form memories were assessed repeatedly.

After just three days of stress, the hippocampus of every stressed rat had shrunk. “Normally structural changes are seen in the brain after a long time — say 10 to 20 days. Three days doesn’t even count as chronic stress,” Chattarji added. Five days after stress exposure, the rats’ hippocampus-based ability to make memories was tested again. The stressed rats were found to perform almost as well as unstressed rats, the researchers said. “Volume loss and shrinkage has happened, yet spatial memory is still holding up,” Chattarji said.

Continue reading “Brain scan during stress may predict memory loss” »

I see many uses for this such as provider services including front office & hospital admissions, security in assessing people in line or trying to gain entry, etc.

Machines are taking over more and more tasks. Ideally, they should also be capable to support the human in case of poor performance. To intervene appropriately, the machine should understand what is going on with the human. Fraunhofer scientists have developed a diagnostic tool that recognizes user states in real time and communicates them to the machine.

The camera firmly focuses on the driver’s eyes. If they are closed for more than one second, an alarm is triggered. This technique prevents the dangerous micro-sleep at the wheel. “It is not always as easy for a machine to detect what state the human is in, as it is in this case,” says Jessica Schwarz from the Fraunhofer Institute for Communication, Information Processing and Ergonomics FKIE in Wachtberg, just south of Bonn.

Continue reading “Computers will be able to assess humans’ state of mind” »

Big Data and 3D.

3D printing remains one of those technological areas that holds a great amount of fascination. What began as a type of niche market has expanded rapidly in the past few years to encompass nearly every industry out there, from the medical field to manufacturing.

The outlook is a positive one in terms of 3D printing’s future, with Gartner predicting the amount of spending on 3D printers to exceed more than $13 billion in 2018. While 3D printing has always held a lot of promise, one of the factors truly taking the concept to the next level is big data.

Continue reading “Big Data’s Role in 3D Printing” »

Nice.

When we think of synthetic biology, we often think of engineering a cell to give it some useful function. But SEED 2016 had quite a few speakers working outside of a biological cell. Some broke open cells to utilize just the cellular machinery to create “cell-free” systems. Others showed what could be done inside of the computer (in silico) to improve our understanding and prediction of synthetic gene networks. Here, we’re highlighting SEED speakers who showed how both of these approaches can advance synthetic biology.

Cell-free synthetic biology

Continue reading “SEED 2016: What can we do outside of a cell?” »

Listen to famed biogerontolgist Aubrey de Grey explain the OncoSENS approach to curing ALT-Cancer (https://www.lifespan.io/campaigns/sens-control-alt-delete-cancer/) and how this is a vital part of overcoming the ill-effects of aging. This presentation is part of the Designing New Advances conference held by the Institute of Exponential Sciences in the Netherlands.

Tempus fugit. I’m just about old enough to remember a time in which 2020 was the distant future of science fiction novels, too far away to be thinking about in concrete terms, a foreign and fantastical land in which anything might happen. Several anythings did in fact happen, such as the internet, and the ongoing revolution in biotechnology that has transformed the laboratory world but leaks into clinics only all too slowly. Here we are, however, close enough to be making plans and figuring out what we expect to be doing when the third decade of the 21st century gets underway. The fantastical becomes the mundane. We don’t yet have regeneration of organs and limbs, or therapies to greatly extend life, but for these and many other staples of golden age science fiction, the scientific community has come close enough to be able to talk in detail about the roads to achieving these goals.

Of all the things that researchers might achieve with biotechnology in the near future, control over aging is by far the most important. Aging is the greatest cause of death and suffering in the world, and none of us are getting any younger. That may change, however. SENS, the Strategies for Engineered Negligible Senescence, is a synthesis of the scientific view of aging as an accumulation of specific forms of cell and tissue damage, pulling in a century of evidence from many diverse areas of medical science to support this conclusion. Aging happens because the normal operation of our cellular biochemistry produces damage, wear and tear at the level of molecules and molecular structures, and some of that damage accumulates to cause failure of tissues and organs, and ultimately death.

Philadelphia, PA, USA / Mexico City, Mexico — Bioquark, Inc., (www.bioquark.com) a life sciences company focused on the development of novel bioproducts for complex regeneration, disease reversion, and aging, and RegenerAge SAPI de CV, (www.regenerage.clinic/en/) a clinical company focused on translational therapeutic applications of a range of regenerative and rejuvenation healthcare interventions, have announced a collaboration to focus on novel combinatorial approaches in human disease and wellness. SGR-Especializada (http://www.sgr-especializada.com/), regulatory experts in the Latin American healthcare market, assisted in the relationship.

“We are very excited about this collaboration with RegenerAge SAPI de CV,” said Ira S. Pastor, CEO, Bioquark Inc. “The natural synergy of our cellular and biologic to applications of regenerative and rejuvenative medicine will make for novel and transformational opportunities in a range of degenerative disorders.”

As we close in on $7 trillion in total annual health care expenditures around the globe ($1 trillion spent on pharmaceutical products; $200 billion on new R&D), we are simultaneously witnessing a paradoxical rise in the prevalence of all chronic degenerative diseases responsible for human suffering and death.

Continue reading “Bioquark Inc. and RegenerAge SAPI de CV to Collaborate on Clinical Regenerative Healthcare” »